Correlation analysis suggested that PRP19 was negatively correlated with DDX5 (R = 0.2122, p = 0.02, Figure 8B) and CD20 (R = −0.4359, p < 0.0001, Figure 8C) expression in HCC patients, and DDX5 was positively associated with CD20 levels (R = −0.2784, p = 0.0021, Figure 8D). This evidence concerns the gene PRPF19 and hepatocellular carcinoma.